These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 24980564)

  • 61. Current modalities and new advances in the treatment of basal cell carcinoma.
    Ceilley RI; Del Rosso JQ
    Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma.
    Ally MS; Aasi S; Wysong A; Teng C; Anderson E; Bailey-Healy I; Oro A; Kim J; Chang AL; Tang JY
    J Am Acad Dermatol; 2014 Nov; 71(5):904-911.e1. PubMed ID: 24929884
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma.
    Mohan SV; Chang J; Li S; Henry AS; Wood DJ; Chang AL
    JAMA Dermatol; 2016 May; 152(5):527-32. PubMed ID: 26914338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complete remission of advanced, locally invasive basal cell carcinoma with vismodegib.
    Glen P; Farrugia D; Farrier J
    Int J Oral Maxillofac Surg; 2020 Sep; 49(9):1149-1152. PubMed ID: 32204965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systemic therapy for inoperable and metastatic basal cell cancer.
    Fecher LA
    Curr Treat Options Oncol; 2013 Jun; 14(2):237-48. PubMed ID: 23558911
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
    Bichakjian CK; Olencki T; Aasi SZ; Alam M; Andersen JS; Berg D; Bowen GM; Cheney RT; Daniels GA; Glass LF; Grekin RC; Grossman K; Higgins SA; Ho AL; Lewis KD; Lydiatt DD; Nehal KS; Nghiem P; Olsen EA; Schmults CD; Sekulic A; Shaha AR; Thorstad WL; Tuli M; Urist MM; Wang TS; Wong SL; Zic JA; Hoffmann KG; Engh A
    J Natl Compr Canc Netw; 2016 May; 14(5):574-97. PubMed ID: 27160235
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib.
    Hehlgans S; Booms P; Güllülü Ö; Sader R; Rödel C; Balermpas P; Rödel F; Ghanaati S
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142876
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up.
    Clover AJP; Salwa SP; Bourke MG; McKiernan J; Forde PF; O'Sullivan ST; Kelly EJ; Soden DM
    Eur J Surg Oncol; 2020 May; 46(5):847-854. PubMed ID: 31862134
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Face and Scalp Basal Cell Carcinoma Treatment: A Review of the Literature.
    Bernardini N; Skroza N; Zuber S; Tolino E; Balduzzi V; Mambrin A; Marchesiello A; Anzalone A; Colapietra D; Proietti I; Potenza C
    Acta Dermatovenerol Croat; 2019 Mar; 27(1):22-27. PubMed ID: 31032787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New perspectives in the management of basal cell carcinoma.
    Martín-Gorgojo A; Pastushenko I
    Actas Dermosifiliogr; 2014 Nov; 105(9):874-5. PubMed ID: 24934656
    [No Abstract]   [Full Text] [Related]  

  • 71. The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma.
    Ching JA; Curtis HL; Braue JA; Kudchadkar RR; Mendoza TI; Messina JL; Cruse CW; Smith DJ; Harrington MA
    Ann Plast Surg; 2015 Jun; 74 Suppl 4():S193-7. PubMed ID: 25695449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New treatment modalities for basal cell carcinoma.
    Stockfleth E; Sterry W
    Recent Results Cancer Res; 2002; 160():259-68. PubMed ID: 12079222
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma.
    Raleigh DR; Algazi A; Arron ST; Neuhaus IM; Yom SS
    Br J Dermatol; 2015 Aug; 173(2):544-6. PubMed ID: 25702621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
    Dummer R; Guminski A; Gutzmer R; Dirix L; Lewis KD; Combemale P; Herd RM; Kaatz M; Loquai C; Stratigos AJ; Schulze HJ; Plummer R; Gogov S; Pallaud C; Yi T; Mone M; Chang AL; Cornélis F; Kudchadkar R; Trefzer U; Lear JT; Sellami D; Migden MR
    J Am Acad Dermatol; 2016 Jul; 75(1):113-125.e5. PubMed ID: 27067394
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Basal cell carcinoma: a paradigm for targeted therapies.
    Dreier J; Felderer L; Barysch M; Rozati S; Dummer R
    Expert Opin Pharmacother; 2013 Jul; 14(10):1307-18. PubMed ID: 23656611
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defining locally advanced Basal cell carcinoma.
    Maly TJ; Sligh JE
    J Drugs Dermatol; 2014 May; 13(5):528-9. PubMed ID: 24809873
    [No Abstract]   [Full Text] [Related]  

  • 78. Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities.
    Spallone G; Sollena P; Ventura A; Fargnoli MC; Gutierrez C; Piccerillo A; Tambone S; Bianchi L; Peris K
    Dermatol Ther; 2019 Nov; 32(6):e13108. PubMed ID: 31606940
    [TBL] [Abstract][Full Text] [Related]  

  • 79. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
    Peris K; Fargnoli MC; Kaufmann R; Arenberger P; Bastholt L; Seguin NB; Bataille V; Brochez L; Del Marmol V; Dummer R; Forsea AM; Gaudy-Marqueste C; Harwood CA; Hauschild A; Höller C; Kandolf L; Kellerners-Smeets NWJ; Lallas A; Leiter U; Malvehy J; Marinović B; Mijuskovic Z; Moreno-Ramirez D; Nagore E; Nathan P; Stratigos AJ; Stockfleth E; Tagliaferri L; Trakatelli M; Vieira R; Zalaudek I; Garbe C;
    Eur J Cancer; 2023 Oct; 192():113254. PubMed ID: 37604067
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Next-generation sequencing of the basal cell carcinoma miRNome and a description of novel microRNA candidates under neoadjuvant vismodegib therapy: an integrative molecular and surgical case study.
    Sand M; Bechara FG; Gambichler T; Sand D; Friedländer MR; Bromba M; Schnabel R; Hessam S
    Ann Oncol; 2016 Feb; 27(2):332-8. PubMed ID: 26578727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.